CABA
Price
$1.67
Change
-$0.07 (-4.02%)
Updated
Jul 14, 01:50 PM (EDT)
Capitalization
156.5M
24 days until earnings call
ORMP
Price
$2.13
Change
-$0.01 (-0.47%)
Updated
Jul 14, 12:32 PM (EDT)
Capitalization
87.22M
30 days until earnings call
Interact to see
Advertisement

CABA vs ORMP

Header iconCABA vs ORMP Comparison
Open Charts CABA vs ORMPBanner chart's image
Cabaletta Bio
Price$1.67
Change-$0.07 (-4.02%)
Volume$300
Capitalization156.5M
Oramed Pharmaceuticals
Price$2.13
Change-$0.01 (-0.47%)
Volume$1K
Capitalization87.22M
CABA vs ORMP Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. ORMP commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (CABA: $1.74 vs. ORMP: $2.13)
Brand notoriety: CABA and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 32% vs. ORMP: 25%
Market capitalization -- CABA: $156.5M vs. ORMP: $87.22M
CABA [@Biotechnology] is valued at $156.5M. ORMP’s [@Biotechnology] market capitalization is $87.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 6 bearish.
  • ORMP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CABA is a better buy in the short-term than ORMP.

Price Growth

CABA (@Biotechnology) experienced а +6.75% price change this week, while ORMP (@Biotechnology) price change was -2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.15%. For the same industry, the average monthly price growth was +23.60%, and the average quarterly price growth was +32.61%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+13.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($157M) has a higher market cap than ORMP($87.2M). ORMP YTD gains are higher at: -11.777 vs. CABA (-23.348). ORMP has higher annual earnings (EBITDA): -21.53M vs. CABA (-123.92M). CABA (132M) and ORMP (131M) have equal amount of cash in the bank . ORMP has less debt than CABA: ORMP (301K) vs CABA (28.8M). ORMP has higher revenues than CABA: ORMP (2M) vs CABA (0).
CABAORMPCABA / ORMP
Capitalization157M87.2M180%
EBITDA-123.92M-21.53M576%
Gain YTD-23.348-11.777198%
P/E RatioN/A20.91-
Revenue02M-
Total Cash132M131M101%
Total Debt28.8M301K9,568%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAORMP
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 18 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIGEF11.87N/A
N/A
Pigeon Corp.
PRDSF5.93N/A
N/A
Prada Spa
WHTAF40.01N/A
N/A
WashTec AG AUGSBURG
QDROF0.02N/A
N/A
Quadro Resources Ltd.
NRVTF0.07-0.01
-6.67%
NORAM LITHIUM CORP